Norges Bank
TTPH

Norges Bank’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Norges Bank’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,908
Closed -$164K – 2182
2016
Q2 		$164K Hold
1,908
– – ﹤0.01% 2156
2016
Q1 		$177K Sell
1,908
-15,254
-89% -$1.52M ﹤0.01% 2169
2015
Q4 		$3.44M Hold
17,162
– – ﹤0.01% 1943
2015
Q3 		$2.56M Buy
17,162
+15,254
+799% +$11.2M ﹤0.01% 2002
2015
Q2 		$1.81M Hold
1,908
– – ﹤0.01% 2058
2015
Q1 		$1.4M Buy
+1,908
New +$1.43M ﹤0.01% 2121

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Norges Bank's TTPH Position: Q3 2016 in Review

Norges Bank sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2016, closing a stake of 1,908 shares — an estimated $164K sold.

Norges Bank first reported a position in TTPH in Q1 2015 and held it in 6 quarters. The position peaked at $3.44M in Q4 2015. 90 funds tracked by Wall St. Rank hold TTPH as of Q3 2016.

  • Norges Bank reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Norges Bank sold 1,908 Tetraphase Pharmaceuticals, Inc. shares in Q3 2016, an estimated $164K.
  • Norges Bank first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
  • Norges Bank's Tetraphase Pharmaceuticals, Inc. position peaked at $3.44M in Q4 2015.
  • 90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2016.

Based on Norges Bank's 13F filing for Q3 2016, filed 14 Nov 2016.